After losing $589B in market cap on Monday, shares of Nvidia (NVDA) climbed about 4% premarket on Tuesday, showing signs of ...

J.P. Morgan Asset Management today released its seventh annual Global Alternatives Outlook, providing a 12-to-18 month ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

CF Industries (NYSE:CF) -6.8% in Friday's trading as J.P. Morgan downgrades shares to Underweight from Neutral with a $75 ...

Jan 16 (Reuters) - J.P.Morgan estimated spending on data centers could contribute between 10-20 basis points to U.S. economic ...

In a report released today, Jessica Fye from J.P. Morgan maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price target ...

LONDON - J.P. Morgan Securities PLC has announced its role as the Stabilisation Coordinator for the Arab Republic of Egypt's latest bond issuance, signaling the potential use of stabilization measures ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

J.P. Morgan analyst Ranjan Sharma maintained a Buy rating on Grab (GRAB – Research Report) on January 21 and set a price target of $5.60. The ...

Jamie Dimon, chairman and CEO, noted in the release that in the asset and wealth management division client net inflows ...

A tide change is rippling across healthcare. As industry leaders converged on San Francisco for the 2025 JP Morgan Healthcare conference, they echoed optimism about a renewed stability in healthcare, ...